Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,229 | 38,500 | 47,086 | 35,004 | 50,588 |
| Marketable Securities | 53,176 | 54,927 | 51,097 | 52,321 | 49,466 |
| Receivables | 120,110 | 141,307 | 61,090 | 66,292 | 54,120 |
| Inventories | 24,120 | 24,763 | 32,880 | 39,403 | 38,308 |
| TOTAL | $216,646 | $263,573 | $210,209 | $213,550 | $202,549 |
| Non-Current Assets | |||||
| PPE Net | 444 | 479 | 515 | 550 | 586 |
| Intangibles | 48,908 | 54,711 | 62,006 | 71,238 | 80,471 |
| Other Non-Current Assets | 972 | 1,012 | 1,050 | 1,088 | 1,126 |
| TOTAL | $50,324 | $56,202 | $63,571 | $72,876 | $82,183 |
| Total Assets | $266,970 | $319,775 | $273,780 | $286,426 | $284,732 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,014 | 14,664 | 10,854 | 8,896 | 14,736 |
| Accrued Expenses | 113,648 | 146,799 | 116,942 | 115,167 | 95,151 |
| Other current liabilities | 4,851 | 5,320 | 4,733 | 4,769 | 4,801 |
| TOTAL | $127,513 | $166,783 | $132,529 | $128,832 | $114,688 |
| Non-Current Liabilities | |||||
| Long Term Debt | 39,124 | 39,166 | 39,046 | 38,929 | 38,813 |
| Other Non-Current Liabilities | 6,381 | 8,023 | 8,907 | 10,135 | 10,150 |
| TOTAL | $45,505 | $47,189 | $47,953 | $49,064 | $48,963 |
| Total Liabilities | $173,018 | $213,972 | $180,482 | $177,896 | $163,651 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,445 | 6,420 | 6,419 | 6,389 | 6,388 |
| Common Shares | 1 | 9 | 9 | 9 | 1 |
| Retained earnings | -703,499 | -691,572 | -703,017 | -686,665 | -673,124 |
| TOTAL | $93,952 | $105,803 | $93,298 | $108,530 | $121,081 |
| Total Liabilities And Equity | $266,970 | $319,775 | $273,780 | $286,426 | $284,732 |